Immunovant Inc
IMVT
Market Cap$2.56B
Close$
$4.71
70.8% downside
Current Fair Value
70.8% downsideOvervalued by 70.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.56 Billion |
|---|---|
| Enterprise Value | $1.96 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.73 |
| Beta | 0.66 |
| Outstanding Shares | 170,872,994 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.61 |
|---|---|
| PEG | -14.61 |
| Price to Sales | - |
| Price to Book Ratio | 5.37 |
| Enterprise Value to Revenue | 12261.28 |
| Enterprise Value to EBIT | -4.4 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data